Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ROBERT C BAST JR and JINSONG LIU.
ROBERT C BAST JR
Connection Strength
1.657
JINSONG LIU
  1. A genetically defined model for human ovarian cancer. Cancer Res. 2004 Mar 01; 64(5):1655-63.
    View in: PubMed
    Score: 0.235
  2. CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Jun; 23(5):815-22.
    View in: PubMed
    Score: 0.112
  3. Paclitaxel inhibits ovarian tumor growth by inducing epithelial cancer cells to benign fibroblast-like cells. Cancer Lett. 2012 Dec 30; 326(2):176-82.
    View in: PubMed
    Score: 0.106
  4. Stanniocalcin 1 and ovarian tumorigenesis. J Natl Cancer Inst. 2010 Jun 02; 102(11):812-27.
    View in: PubMed
    Score: 0.090
  5. Induction of papillary carcinoma in human ovarian surface epithelial cells using combined genetic elements and peritoneal microenvironment. Cell Cycle. 2010 Jan 01; 9(1):140-6.
    View in: PubMed
    Score: 0.088
  6. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Cancer. 2008 Apr 01; 112(7):1489-502.
    View in: PubMed
    Score: 0.078
  7. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer. 2006 Dec 01; 107(11):2730-40.
    View in: PubMed
    Score: 0.071
  8. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis. Proc Natl Acad Sci U S A. 2006 Oct 31; 103(44):16472-7.
    View in: PubMed
    Score: 0.071
  9. Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells. Carcinogenesis. 2007 Jan; 28(1):174-82.
    View in: PubMed
    Score: 0.069
  10. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer. Clin Cancer Res. 2006 Apr 15; 12(8):2404-13.
    View in: PubMed
    Score: 0.068
  11. Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol. 2006; 407:455-68.
    View in: PubMed
    Score: 0.067
  12. Use of Ras-transformed human ovarian surface epithelial cells as a model for studying ovarian cancer. Methods Enzymol. 2006; 407:660-76.
    View in: PubMed
    Score: 0.067
  13. New tumor markers: CA125 and beyond. Int J Gynecol Cancer. 2005 Nov-Dec; 15 Suppl 3:274-81.
    View in: PubMed
    Score: 0.066
  14. Potential markers that complement expression of CA125 in epithelial ovarian cancer. Gynecol Oncol. 2005 Nov; 99(2):267-77.
    View in: PubMed
    Score: 0.065
  15. Subcellular localization of p27kip1 expression predicts poor prognosis in human ovarian cancer. Clin Cancer Res. 2005 Jan 15; 11(2 Pt 1):632-7.
    View in: PubMed
    Score: 0.062
  16. Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival. Clin Cancer Res. 2004 Oct 01; 10(19):6559-66.
    View in: PubMed
    Score: 0.061
  17. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res. 2004 May 15; 10(10):3291-300.
    View in: PubMed
    Score: 0.060
  18. Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovirus-mediated small interfering RNA against Her-2/neu gene expression. J Biol Chem. 2004 Feb 06; 279(6):4339-45.
    View in: PubMed
    Score: 0.058
  19. Early detection of ovarian cancer: promise and reality. Cancer Treat Res. 2002; 107:61-97.
    View in: PubMed
    Score: 0.051
  20. Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog. 2008 Sep; 47(9):701-6.
    View in: PubMed
    Score: 0.020
  21. Correlation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res. 2007; 9(4):R57.
    View in: PubMed
    Score: 0.018
  22. HER2 signaling modulates the equilibrium between pro- and antiangiogenic factors via distinct pathways: implications for HER2-targeted antibody therapy. Oncogene. 2006 Nov 02; 25(52):6986-96.
    View in: PubMed
    Score: 0.017
  23. Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model. Oncogene. 2005 Sep 08; 24(40):6174-84.
    View in: PubMed
    Score: 0.016
  24. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon. Clin Cancer Res. 2005 Sep 01; 11(17):6116-26.
    View in: PubMed
    Score: 0.016
  25. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer. Clin Cancer Res. 2003 Sep 01; 9(10 Pt 1):3660-6.
    View in: PubMed
    Score: 0.014
  26. The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice. Cancer Res. 2000 Sep 01; 60(17):4913-20.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.